Paul Fraser
- Physiology top 1%
- Molecular Biology top 10%
- Cell Biology top 2%
- Cellular and Molecular Neuroscience top 5%
- Pharmacology top 5%
- Co-authors
- Peter St George‐HyslopLyne LévesqueBart De StrooperBarbara CordellKatleen CraessaertsDavid WestawayWim AnnaertFred Van Leuven
- Topics
- Alzheimer's disease research and treatments (16 papers)Prion Diseases and Protein Misfolding (4 papers)Cholinesterase and Neurodegenerative Diseases (4 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryNature Communications
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Paul Fraser
18 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 82
- Physiology 1.4k
- Molecular Biology 879
- Cell Biology 481
- Cellular and Molecular Neuroscience 420
- Pharmacology 348
Countries citing papers authored by Paul Fraser
This map shows the geographic impact of Paul Fraser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Fraser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Fraser more than expected).
Fields of papers citing papers by Paul Fraser
This network shows the impact of papers produced by Paul Fraser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Fraser. The network helps show where Paul Fraser may publish in the future.
Co-authorship network of co-authors of Paul Fraser
This figure shows the co-authorship network connecting the top 25 collaborators of Paul Fraser. A scholar is included among the top collaborators of Paul Fraser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Fraser. Paul Fraser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 245 | |
| 3 | 80 | |
| 4 | 3 | |
| 5 | 11 | |
| 6 | 39 | |
| 7 | 36 | |
| 8 | 38 | |
| 9 | 23 | |
| 10 | 31 | |
| 11 | 15 | |
| 12 | 130 | |
| 13 | 96 | |
| 14 | 158 | |
| 15 | 283 | |
| 16 | 250 | |
| 17 | 237 | |
| 18 | 126 |
About Paul Fraser
Paul Fraser is a scholar working on Physiology, Neurology and Cell Biology, having authored 18 papers that have together received 1.8k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (16 papers), Prion Diseases and Protein Misfolding (4 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). The work is most often cited by research in Physiology (1.4k citations), Cell Biology (481 citations) and Cellular and Molecular Neuroscience (420 citations). Paul Fraser has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Peter St George‐Hyslop, Lyne Lévesque, Bart De Strooper, Barbara Cordell, Katleen Craessaerts, David Westaway, Wim Annaert, Fred Van Leuven, Monique Beullens and Mathieu Bollen. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.